scholarly journals Studies on the metabolic fate of (.+-.)-1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-isopropylamino-2-propanol hydrochloride (betaxolol hydrochloride). (2): Blood level profiles, distribution, metabolism, excretion, aecumulation and effects on the hepatic drug-metabolizing enzyme activities of betaxolol after repeated oral administration to rats.

1990 ◽  
Vol 5 (5) ◽  
pp. 699-710
Author(s):  
Seiu IIDA ◽  
Tomio INOKUCHI ◽  
Masato IWAMOTO ◽  
Yukimi YONEYAMA ◽  
Jun TATSUNO ◽  
...  
Keyword(s):  
Oral Administration ◽  
Blood Level ◽  
Enzyme Activities ◽  
Metabolic Fate ◽  
Hepatic Drug ◽  
Drug Metabolizing Enzyme ◽  
Metabolizing Enzyme

The Influence of Phenobarbitone on Maternal and Perinatal Hepatic Drug-metabolizing Enzymes in the Rat

1975 ◽  
Vol 53 (6) ◽  
pp. 1147-1157 ◽  
Author(s):  
J. U. Bell ◽  
M. M. Hansell ◽  
D. J. Ecobichon
Keyword(s):  
Endoplasmic Reticulum ◽  
Enzyme Activities ◽  
Morphological Changes ◽  
Smooth Endoplasmic Reticulum ◽  
Transplacental Passage ◽  
Hepatic Drug ◽  
Rat Pups ◽  
Drug Metabolizing Enzyme ◽  
Metabolizing Enzyme ◽  
Conjugating Enzyme

Phenobarbitone (PB) (75 mg/kg) was administered orally for three consecutive days to pregnant or lactating rats at different pre- and postnatal stages in order that the perinatal animals would receive the agent either by transplacental passage or via the milk. Control animals received equivalent volumes of saline. The dams, fetuses, and pups were killed 24 h after the last dose. Hepatic p-nitroanisole O-demethylase (OD), carboxylesterase (CE), and bromosulfophthalein–glutathione (BSP–GSH) conjugating enzyme activities in a 12 100 g – 20 min supernatant of a 20% w/v homogenate were measured. The morphology of the developing rat liver in the absence and presence of PB was examined by electron microscopy.The results demonstrated that the transplacental passage of PB to rat fetuses at term or 3 days prepartum had no effect on either the hepatic drug-metabolizing enzyme activities or on the ultrastructural appearance of the liver. Increased hepatic OD activity was observed in the pregnant animal but no effect was observed in the lactating dam. Phenobarbitone received by the suckling rat had two distinct effects. Compared to control activities, twofold increases in hepatic OD activity were observed in rat pups as early as 4 days after birth, associated with a marked proliferation in hepatic smooth endoplasmic reticulum. In contrast, PB-related significant increases in neonatal hepatic CE and BSP–GSH conjugating enzyme activities were not observed until 21 days of age. In the 4-day-old treated pups, characteristic morphological changes included numerous small membrane whorls in addition to increased smooth endoplasmic reticulum and microbodies in the liver.

scholarly journals The changes of hepatic drug-metabolizing enzyme activities during the estrus cycle in rats.

1996 ◽  
Vol 71 ◽  
pp. 127
Author(s):  
Minoru Watanabe ◽  
Hironori Nakura ◽  
Masami Tanaka ◽  
Toshio Kumai ◽  
Tomonori Tateishi ◽  
...  
Keyword(s):  
Enzyme Activities ◽  
Estrus Cycle ◽  
Hepatic Drug ◽  
Drug Metabolizing Enzyme ◽  
Metabolizing Enzyme
Sign in / Sign up

Export Citation Format

Share Document